Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zheng L et al. | [Changes of thromboxane A2 (TXA2) and prostacyclin (PGI2) in COPD patients with pulmonary hypertension]. | 1991 | Zhonghua Nei Ke Za Zhi | pmid:1864178 |
Liu HY et al. | [Changes in parameters of hemorheology and circulation 6-keto-PGF1 alpha and TXB2 in dilated cardiomyopathy]. | 1991 | Zhonghua Nei Ke Za Zhi | pmid:1874088 |
Zhang ZF et al. | [The changes in serum TXB2 and 6-keto-PGF1 alpha in 62 cases with renal disease]. | 1989 | Zhonghua Nei Ke Za Zhi | pmid:2737033 |
Dong DC and Zhong L | [Measurement of urinary TXB2, 6-keto-PGF1 alpha by radioimmunoassay and its clinical significance]. | 1987 | Zhonghua Nei Ke Za Zhi | pmid:3451855 |
Wang M | [Studies on plasma beta-thromboglobulin, thromboxane A2, prostaglandin I2 concentration and platelet count in liver diseases]. | 1992 | Zhonghua Nei Ke Za Zhi | pmid:1395919 |
Mei XW et al. | [The interaction of some active and immunological factors in blood in the development of chronic cor pulmonale]. | 1992 | Zhonghua Nei Ke Za Zhi | pmid:1395928 |
Liu H et al. | [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease]. | 1995 | Zhonghua Nei Ke Za Zhi | pmid:8697924 |
Pan YZ et al. | [The clinical significance of platelet activation during exercise-induced myocardial ischemia]. | 1994 | Zhonghua Nei Ke Za Zhi | pmid:7520851 |
Jin L et al. | [The effect of low dose aspirin on the platelet function in patients with acute myocardial infarction]. | 1993 | Zhonghua Nei Ke Za Zhi | pmid:8269785 |
Wang S | [The effect of captopril on hemodynamics in patients of chronic obstructive pulmonary disease with pulmonary hypertension]. | 1993 | Zhonghua Nei Ke Za Zhi | pmid:8269786 |